Cargando…
Stents Eluting 6-Mercaptopurine Reduce Neointima Formation and Inflammation while Enhancing Strut Coverage in Rabbits
BACKGROUND: The introduction of drug-eluting stents (DES) has dramatically reduced restenosis rates compared with bare metal stents, but in-stent thrombosis remains a safety concern, necessitating prolonged dual anti-platelet therapy. The drug 6-Mercaptopurine (6-MP) has been shown to have beneficia...
Autores principales: | Ruiter, Matthijs S., van Tiel, Claudia M., Doornbos, Albert, Marinković, Goran, Strang, Aart C., Attevelt, Nico J. M., de Waard, Vivian, de Winter, Robbert J., Steendam, Rob, de Vries, Carlie J. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4577071/ https://www.ncbi.nlm.nih.gov/pubmed/26389595 http://dx.doi.org/10.1371/journal.pone.0138459 |
Ejemplares similares
-
Long-term effect of stents eluting 6-mercaptopurine in porcine coronary arteries
por: Ruiter, Matthijs S., et al.
Publicado: (2016) -
Effect of Anti-ApoA-I Antibody-Coating of Stents on Neointima Formation in a Rabbit Balloon-Injury Model
por: Strang, Aart C., et al.
Publicado: (2015) -
Influence of valsartan-eluting stent on neointima formation
por: Guihua, Li, et al.
Publicado: (2010) -
Endovascular procedures cause transient endothelial injury but do not disrupt mature neointima in Drug Eluting Stents
por: Autar, Anouchska, et al.
Publicado: (2020) -
Is There an Advantage of Ultrathin-Strut Drug-Eluting Stents over Second- and Third-Generation Drug-Eluting Stents?
por: Gherasie, Flavius-Alexandru, et al.
Publicado: (2023)